RhumbLine Advisers
HGEN

RhumbLine Advisers’s HUMANIGEN, INC. HGEN Stock Holding History

RhumbLine Advisers’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-46,361
Closed -$140K – 3300
2022
Q1 		$140K Buy
46,361
+1,354
+3% +$3.62K ﹤0.01% 2832
2021
Q4 		$167K Sell
45,007
-796
-2% -$4.66K ﹤0.01% 2873
2021
Q3 		$272K Buy
45,803
+2,143
+5% +$30.1K ﹤0.01% 2804
2021
Q2 		$759K Buy
+43,660
New +$796K ﹤0.01% 2369

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RhumbLine Advisers's HGEN Position: Q2 2022 in Review

RhumbLine Advisers sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 46,361 shares — an estimated $140K sold.

RhumbLine Advisers first reported a position in HGEN in Q2 2021 and held it in 4 quarters. The position peaked at $759K in Q2 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • RhumbLine Advisers reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 46,361 HUMANIGEN, INC. shares in Q2 2022, an estimated $140K.
  • RhumbLine Advisers first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 4 quarters.
  • RhumbLine Advisers's HUMANIGEN, INC. position peaked at $759K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.